Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

Background: This study aimed to evaluate short- and long-term humoral and T-cell-specific immune responses to SARS-CoV-2 vaccines in patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs). Methods: Single-center observational longitudinal study including 102...

Descripción completa

Detalles Bibliográficos
Autores principales: Sainz de la Maza, Susana, Walo-Delgado, Paulette Esperanza, Rodríguez-Domínguez, Mario, Monreal, Enric, Rodero-Romero, Alexander, Chico-García, Juan Luis, Pariente, Roberto, Rodríguez-Jorge, Fernando, Ballester-González, Rubén, Villarrubia, Noelia, Romero-Hernández, Beatriz, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145338/
https://www.ncbi.nlm.nih.gov/pubmed/37112698
http://dx.doi.org/10.3390/vaccines11040786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145338/
https://www.ncbi.nlm.nih.gov/pubmed/37112698
http://dx.doi.org/10.3390/vaccines11040786

Ejemplares similares